Abstract

Introduction Ectopic pituitary tumors (EPT) are very rare comparing to eutopic ones. Their mechanism is still debated. Our aim was to report 10 cases observed in our practice. Cases series Six prolactinomas and 4 somatotropinomas were collected. They were located in the suprasellar area for 3: two prolactinomas and one somatotropinoma, in the clivus for 3: 2 prolactinomas and one somatotropinoma, or in the sphenoid sinus n = 4: 2 prolactinomas and 2 somatotropinomas. For the infrasellar lesions, the diagnosis was relatively easy as the tumors were visible in infrasellar position and were associated to an empty sellar suggesting an inhibition of the pituitary gland by an ectopic hormonal secretion. Regarding suprasellar lesions, the 3 tumors invaded the pituitary area. The diagnosis was made in retrospect after tumor shrinkage due to medical treatment. Actually, MRI done after dopamine agonists or somatostatin analogues showed a quick disappearance of the intrasellar part of the tumor first, and then it was the suprasellar part turn. After the last control, only a very small residual tumor was visible in the suprasellar area. On the therapeutic point, we remarked that inhibition of prolactin and growth hormone secretion was similar in both positions; however tumor shrinkage was better in suprasellar tumors. Conclusion Those 10 unusual cases should be known for their rarity, their unknown physiopathology and their response to medical treatment.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.